Dexamethasone Intravitreal Implant After Vitrectomy For Epiretinal Membrane
Status:
Terminated
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of dexamethasone intravitreal implant
(Ozurdex) in combination with pars plana vitrectomy and membrane peeling for idiopathic
epiretinal membrane (ERM).